AustraliaBreaking News

Bloomberg

J&J Is Focused on Fighting Cancer, Not Obesity Drugs, CEO Says

Johnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer, CEO Joaquin Duato said in an interview for an upcoming episode of The David Rubenstein Show: Peer to Peer Conversations. The comments set J&J apart from many of its rivals that are trying to develop or acquire obesity medicines following blockbuster weight-loss drugs from Eli Lilly & Co. and Novo Nordisk.

Read more
Bloomberg

Seeking to Raise $300M, Create Unique Structure: LIV CEO

Scott O'Neil, CEO of LIV Golf, joins Dani Burger and Scarlet Fu on "Bloomberg Deals." LIV Golf has begun laying the groundwork for a potential US bankruptcy filing if it fails to raise new funds, according to people familiar with the matter. The golf league is currently looking for money after its main backer, the Saudi Public Investment Fund, pulled its funding.

Read more
Bloomberg

Apple to Launch Camera Airpods, Foldable iPhone in 2027

Apple is holding steady with its AI ambitions, planning camera-equipped AirPods, smart glasses and new foldable iPhones as part of a major product push over the next two years. Plus: Snap introduces Specs, a pair of augmented reality glasses that co-founder Evan Spiegel described as a 'leapfrog advancement' and the computer of the future. Bloomberg's Mark Gurman joins Ed Ludlow on "Bloomberg Tech."

Read more

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.